Lawlor E, Johnson Z, Thornton L, Temperley I
Blood Transfusion Service Board, St. James's Hospital, Dublin, Ireland.
Vox Sang. 1994;67 Suppl 1:18-9; discussion 20.
Since 1990, Irish haemophilia A patients have been treated with solvent-detergent(SD)-treated virally inactivated high-purity factor VIII concentrate prepared from plasma from Irish voluntary non-remunerated donors. In 1992, 13 haemophilia A patients developed clinical hepatitis A and a further 17 patients showed serological evidence of recent infection by hepatitis A. All but 3 of these patients had had recent exposure to SD-treated product. A case-control study is underway to determine whether these cases represent transmission through product or environmentally acquired hepatitis A.
